Lilly (Eli) & Co. Note Agreements

12 Contracts & Agreements
Recent Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
Eli Lilly and Company 1.625% Notes Due 2043—Description of Debt Securities
Note Agreements
Lilly (Eli) & Co.
Pharmaceuticals
2022
Description of Eli Lilly and Company’s 0.500%, 1.125%, and 1.375% Euro-Denominated Notes Due 2033, 2051, and 2061
Note Agreements
Lilly (Eli) & Co.
Pharmaceuticals
2022
Description of Eli Lilly and Company’s 0.625% and 1.700% Euro Notes Due 2031 and 2049
Note Agreements
Lilly (Eli) & Co.
Pharmaceuticals
2020
Description of Eli Lilly and Company 7 1/8% Notes Due 2025
Note Agreements
Lilly (Eli) & Co.
Pharmaceuticals
2020
Description of Eli Lilly and Company 6.77% Notes Due 2036
Note Agreements
Lilly (Eli) & Co.
Pharmaceuticals
2020
Description of Eli Lilly and Company’s 1.000% Notes Due 2022, 1.625% Notes Due 2026, and 2.125% Notes Due 2030
Note Agreements
Lilly (Eli) & Co.
Pharmaceuticals
2020
Eli Lilly and Company Officers’ Certificate Establishing Terms of 2015 Euro-Denominated Notes under Indenture
Note Agreements
Lilly (Eli) & Co.
Pharmaceuticals
2015
Eli Lilly and Company 5.55% Note Due 2037 Certificate (Indenture with Citibank, N.A. as Trustee)
Note Agreements
Lilly (Eli) & Co.
Pharmaceuticals
2007
Eli Lilly and Company 5.50% Note Due 2027 Certificate (Indenture with Citibank, N.A. as Trustee)
Note Agreements
Lilly (Eli) & Co.
Pharmaceuticals
2007
Eli Lilly and Company 5.20% Note Due 2017 Certificate (Indenture: Citibank, N.A. as Trustee)
Note Agreements
Lilly (Eli) & Co.
Pharmaceuticals
2007
Eli Lilly and Company 4.50% Note Due 2018 (Form of Global Note)
Note Agreements
Lilly (Eli) & Co.
Pharmaceuticals
2003
Eli Lilly and Company 2.90% Note Due 2008 (Indenture with Citibank, N.A. as Trustee)
Note Agreements
Lilly (Eli) & Co.
Pharmaceuticals
2003